Nepsis Inc. United Therapeutics Corp Transaction History
Nepsis Inc.
- $289 Million
- Q2 2025
A detailed history of Nepsis Inc. transactions in United Therapeutics Corp stock. As of the latest transaction made, Nepsis Inc. holds 47,772 shares of UTHR stock, worth $14.2 Million. This represents 4.74% of its overall portfolio holdings.
Number of Shares
47,772
Previous 58,574
18.44%
Holding current value
$14.2 Million
Previous $18.1 Million
23.98%
% of portfolio
4.74%
Previous 5.23%
Shares
4 transactions
Others Institutions Holding UTHR
# of Institutions
733Shares Held
43.4MCall Options Held
124KPut Options Held
122K-
Black Rock Inc. New York, NY5.47MShares$1.63 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.46MShares$1.33 Billion0.03% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.68MShares$795 Million13.34% of portfolio
-
State Street Corp Boston, MA2.23MShares$663 Million0.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.11MShares$626 Million1.04% of portfolio
About UNITED THERAPEUTICS Corp
- Ticker UTHR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,516,300
- Market Cap $13.5B
- Description
- United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...